The majority of colorectal cancer CRCs exhibit genetic changes in the WNT pathway, such as APC mutations, activating mutations in CTNNB1 (β-catenin), etc., which could encourage the initial growth of the tumor [143–145]. This evidence concerns the gene APC and colorectal cancer.